Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REMODEL I: Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen

NCT07575568 is registered in ClinicalTrials.gov with Cagent Vascular LLC as lead sponsor.

NCT NCT07575568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07575568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REMODEL I: Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen
Lead sponsor
Cagent Vascular LLC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
September 30, 2027
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease